Truscreen Group Ltd (TRU) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.502x

Based on the latest financial reports, Truscreen Group Ltd (TRU) has a cash flow conversion efficiency ratio of -0.502x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-1.68 Million ≈ $-1.19 Million USD) by net assets (AU$3.35 Million ≈ $2.37 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Truscreen Group Ltd balance sheet independence to measure how much of total assets are equity-financed.

Truscreen Group Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)

This chart illustrates how Truscreen Group Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check TRU cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Truscreen Group Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Truscreen Group Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
RH Bophelo Ltd
JSE:RHB
-0.003x
Fly Play hf.
IC:PLAY
N/A
BAWAT WATER TECHNOLOGIES
F:M5W
0.190x
Atlas Cycles (Haryana) Limited
NSE:ATLASCYCLE
0.001x
EAT WELL INVESTMENT GROUP
F:6BC0
N/A
Hube Yangfan Holding Co Ltd
SHG:600421
-0.156x
Diamond Estates Wines & Spirits Inc
V:DWS
-0.017x
Straits Inter Logistics Bhd
KLSE:0080
-0.018x

Annual Cash Flow Conversion Efficiency for Truscreen Group Ltd (2013–2024)

The table below shows the annual cash flow conversion efficiency of Truscreen Group Ltd from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Truscreen Group Ltd.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 AU$1.01 Million
≈ $713.49K
AU$-2.29 Million
≈ $-1.62 Million
-2.270x -260.88%
2023-12-31 AU$3.23 Million
≈ $2.29 Million
AU$-2.03 Million
≈ $-1.44 Million
-0.629x +27.11%
2022-12-31 AU$2.54 Million
≈ $1.80 Million
AU$-2.19 Million
≈ $-1.55 Million
-0.863x -15.73%
2021-12-31 AU$3.40 Million
≈ $2.40 Million
AU$-2.53 Million
≈ $-1.79 Million
-0.746x -285.20%
2020-12-31 AU$11.31 Million
≈ $8.00 Million
AU$-2.19 Million
≈ $-1.55 Million
-0.194x +14.24%
2019-12-31 AU$7.24 Million
≈ $5.12 Million
AU$-1.63 Million
≈ $-1.16 Million
-0.226x +4.59%
2018-12-31 AU$11.32 Million
≈ $8.01 Million
AU$-2.68 Million
≈ $-1.90 Million
-0.237x +26.31%
2017-12-31 AU$11.62 Million
≈ $8.22 Million
AU$-3.73 Million
≈ $-2.64 Million
-0.321x -78.55%
2016-12-31 AU$14.32 Million
≈ $10.14 Million
AU$-2.58 Million
≈ $-1.82 Million
-0.180x -284.17%
2015-12-31 AU$14.15 Million
≈ $10.01 Million
AU$-662.10K
≈ $-468.48K
-0.047x +69.78%
2014-12-31 AU$9.86 Million
≈ $6.97 Million
AU$-1.53 Million
≈ $-1.08 Million
-0.155x -321.40%
2013-12-31 AU$10.40 Million
≈ $7.36 Million
AU$-382.34K
≈ $-270.53K
-0.037x --

About Truscreen Group Ltd

AU:TRU Australia Medical Devices
Market Cap
$6.87 Million
AU$9.72 Million AUD
Market Cap Rank
#27907 Global
#1424 in Australia
Share Price
AU$0.01
Change (1 day)
+0.00%
52-Week Range
AU$0.01 - AU$0.02
All Time High
AU$0.16
About

TruScreen Group Limited, together with its subsidiaries, develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, and the Middle East/North Africa. It offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The comp… Read more